Your body contains roughly 20,000 different kinds of proteins. Each one is a tiny machine that folds, twists, and flexes thousands of times per second to do its job: digesting food, firing neurons, fighting infections. When one of those machines jams or snaps into the wrong shape, you get disease. But for decades, watching a single protein change shape in real time has been like trying to film a hummingbird’s wings with a pinhole camera. The motions are too fast, the proteins are too small, and the measurement tools introduce too much noise.

Researchers at the University of Queensland just solved that problem. In a paper posted to arXiv on July 17, they describe a silicon-chip sensor that can track the shape changes of a single protein molecule at sub-microsecond speeds, continuously, for minutes at a time. No fluorescent dyes, no averaging over millions of molecules, no physical tether that might alter the protein’s behavior. The device is a nanoscale stethoscope pressed up against a single molecule, and it’s revealing things about protein motion that nobody had seen before.

In 2023, the world spent over $200 billion on antibody drugs — treatments like Keytruda for cancer and Humira for autoimmune disease. But finding a single antibody that binds well enough to become a drug is like searching for a specific grain of sand on a beach. A typical drug discovery campaign screens thousands of candidates, each one requiring expensive lab tests to measure how tightly it grabs its target. Most fail.

Enerzyme: The AI That Can Watch Enzymes Work

Inside every living cell, enzymes are running the chemistry of life, snipping, splicing, and assembling molecules with a precision that industrial chemists can only dream of. A single enzyme can catalyze a million reactions per second. The problem? Understanding how they do it has been painfully slow. Even with GPU-accelerated quantum chemistry, simulating a single step in an enzymatic reaction on a cluster of 300 atoms can take hours. Mapping a full reaction pathway takes days.

Now researchers at MIT have built something that changes the math entirely.

Heather Kulik’s group released Enerzyme, an open-source framework that trains neural networks to simulate enzyme catalysis with near-quantum-chemical accuracy, but at a fraction of the cost. The key breakthrough isn’t a better algorithm. It’s that Enerzyme handles everything that makes enzymes uniquely hard to model: their size, their solvent environment, and the complex charge transfers that drive their chemistry.